Drug Shortage Report for RABAVERT

Last updated on 2017-08-31 History
Report ID 3285
Drug Identification Number 02267667
Brand name RABAVERT
Common or Proper name Rabies vaccine
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) RABIES VACCINE INACTIVATED
Strength(s) 2.5UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BG
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-27
Estimated end date 2017-08-31
Actual end date 2017-08-30
Shortage status Resolved
Updated date 2017-08-31
Company comments Supply released July 18, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2017-08-31 English Compare
v33 2017-08-30 French Compare
v32 2017-08-30 English Compare
v31 2017-08-30 English Compare
v30 2017-08-23 French Compare
v29 2017-08-23 English Compare
v28 2017-08-03 French Compare
v27 2017-08-03 English Compare
v26 2017-07-21 French Compare
v25 2017-07-21 English Compare
v24 2017-07-20 French Compare
v23 2017-07-20 English Compare
v22 2017-07-20 English Compare
v21 2017-07-19 English Compare
v20 2017-07-18 French Compare
v19 2017-07-18 English Compare
v18 2017-07-05 French Compare
v17 2017-07-05 English Compare
v16 2017-06-15 French Compare
v15 2017-06-15 English Compare

Showing 1 to 20 of 34